home / stock / sibn / sibn news

SIBN News and Press, SI-BONE Inc. From 08/02/21

Stock Information
Company Name: SI-BONE Inc.
Stock Symbol: SIBN
Market: NASDAQ
Website: si-bone.com
Menu
SIBN SIBN Quote SIBN Short SIBN News SIBN Articles SIBN Message Board
Get SIBN Alerts

News, Short Squeeze, Breakout and More Instantly...
SIBN - SI-BONE EPS misses by $0.02, beats on revenue

SI-BONE (NASDAQ:SIBN): Q2 GAAP EPS of -$0.42 misses by $0.02. Revenue of $22.19M (+57.9% Y/Y) beats by $0.46M. Cash and marketable securities were $176.6 million and long-term borrowings were $39.6 million as of June 30, 2021. 2021 Guidance: The Company continues to take a measured appro...
SIBN - SI-BONE, Inc. Reports Second Quarter 2021 Financial Results and Announces Exclusive Coverage from Anthem

SANTA CLARA, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended June 30, 2021. Recent Highlights Rec...

SIBN - SI-BONE, Inc. Announces Anthem, Inc. Adopts Coverage Guidelines for Sacroiliac Joint Fusion Exclusive to the Triangular iFuse Implant System® for Its More Than 40 Million Members

SANTA CLARA, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that Anthem, Inc. will cover minimally invasive SI joint fusion exclu...

SIBN - SI-BONE to Present at the Canaccord Genuity 41st Annual Growth Conference

SANTA CLARA, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Canaccord Genuity 41 st An...
SIBN - SI-BONE To Report Second Quarter 2021 Financial Results on August 2, 2021

SANTA CLARA, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2021 after market close on Mond...

SIBN - SI-BONE, Inc. Announces Centene Establishes Positive Coverage for MIS SI Joint Fusion including the Triangular iFuse Implant System

SANTA CLARA, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that Centene Corporation has established a positive coverage policy ...

SIBN - SI-BONE, Inc. Announces Publication of iFuse-3D Implant Clinical Study Results Showing Accelerated Fusion, Immediate and Sustained Clinical Improvements and Reduction in Opioid Use

SANTA CLARA, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy announced the publication of 2-year results from SALLY ( S tudy of bone growth in...
SIBN - SI-BONE, Inc. Announces the Introduction of the SI-BONE SImulator(TM) Powered by Medability for iFuse Surgeon Training and Education

SANTA CLARA, Calif., July 02, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the worldwide launch of the SI-BONE SImulator™. The SI-...

SIBN - French National Healthcare System Adopts Exclusive Reimbursement Policy for SI-BONE, Inc.'s iFuse-3D Implant System(TM)

SANTA CLARA, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy announced that the French Health Ministry has granted national reimbursement for the ...

SIBN - SI-BONE to Present at the 2021 JMP Securities Life Sciences Conference

SANTA CLARA, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2021 JMP Securities Life Scien...
Previous 10 Next 10